Skip to main content

A senator found Medicare blowing hundreds of millions on a drug private insurers wouldn't touch — and nothing happened

April 06, 2017

"As stewards of the taxpayer, we need to know why CMS continues to pay for [Acthar] when Tricare and the nation's top insurance providers have severely restricted reimbursements for this drug," Sen. Tim Scott (R-SC) said in a letter to CMS.

 

Full story


Get the latest on healthcare leadership in your inbox.